12 Jun 2019

DEADLINE EXTENDED: Be Part of the GNP+ Board!

In an effort to ensure diversity of Board membership in terms of geographical representation, gender and skills sets, GNP+ is extending the call for Board membership application.

GNP+ calls for interested and skilled people living with HIV to join our Board. This is an open call to all people living with HIV (including key populations living with HIV) from all ages and every walk of life.

Are you living with HIV? Are you loaded with skills and expertise you are willing to share? Do you know what is lacking in the HIV response? Do you have a vision on how we can improve the quality of life of people living with HIV worldwide? If so, apply to become a Board Member of the Global Network of People living with HIV!

Selection Process

The Board Member selection process is a step-wise process. Applicants will, at every step of the process, be informed of the status of their application. After the deadline, a Board sub-committee will first check the applications for the basic criteria and from the remaining applicants a shortlist will be developed. The shortlist will be reviewed, and a reference check and interviews will take place. The sub-committee will develop a report from these interviews and reference checks. The Board will then meet by teleconference to make selections of the new Board members. The final selection will be announced by 12th of July, 2019.

Check this link to access the Application Form and read more about the new GNP+ structure and what we seek in a Board Member in this link.

Please return all completed applications to recruitment@gnpplus.netwith subject: GNP+ Board Application 2019

Deadline for applications 20th of June, 2019.



Share this
COVID-19 and People Living with HIVGet information about COVID-19

The dedicated page on COVID-19 brings together information, resources and most importantly the many inspiring ways our communities are responding and taking action to protect the rights of people living with HIV.

Read more about COVID-19